Irvine: Johnson & Johnson MedTech, an emerging leader in neurovascular care, has announced the launch of the CEREGLIDE 92 ...
RenovoRx, Inc. ("RenovoRx" or the "Company") , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, an innovative, FDA-cleared device, highlighted its ...
Many consumer devices undergo the FDA clearance process, such as LED masks and fitness trackers that have features like ...
RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, an innovative, FDA-cleared device, ...
Medtronic will use the technology to develop PEEK interbody spine fusion devices that enhance implant fixation.
The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...